5,901 followers
RT @PGrivasMDPhD: Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great…
3,275 followers
RT @PGrivasMDPhD: Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great…
40 followers
RT @TargetOncology: Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to S…
291 followers
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies https://t.co/MQlkHoUwh7
3,732 followers
RT @PGrivasMDPhD: Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great…
6,760 followers
RT @PGrivasMDPhD: Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great…
1,389 followers
RT @PGrivasMDPhD: Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great…
6,530 followers
RT @PGrivasMDPhD: Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great…
4,306 followers
RT @PGrivasMDPhD: Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great…
16,138 followers
Check out our recent paper regarding post IO Tx options in mUC. Always a pleasure to work with awesome fellows and great colleagues #CleClinicCancer @SeattleCCA @fredhutch @UWMedicine @B_C_A_N https://t.co/crTarVHLgL